Visudyne and Uveitis - a phase IV clinical study of FDA data

Summary:

Uveitis is reported as a side effect among people who take Visudyne (verteporfin), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Avastin, and have Macular degeneration.

The phase IV clinical study analyzes which people have Uveitis when taking Visudyne. It is created by eHealthMe based on reports of 3,123 people who have side effects when taking Visudyne from the FDA, and is updated regularly.

What is Visudyne?

Visudyne has active ingredients of verteporfin. eHealthMe is studying from 3,124 Visudyne users. Check the latest studies of Visudyne.

What is Uveitis?

Uveitis (inflammation of the uvea) is found to be associated with 852 drugs and 1,501 conditions by eHealthMe. Check the latest studies of Uveitis.

On Jan, 01, 2026

3,123 people reported to have side effects when taking Visudyne.
Among them, 12 people (0.38%) have Uveitis.

Among these 12 people:

How long have people been on Visudyne when they have Uveitis? *

What is the gender of people who have Uveitis when taking Visudyne? *

female: 81.82 %
male: 18.18 %

What is the age of people who have Uveitis when taking Visudyne? *

What are other drugs people take besides Visudyne? *

Avastin: 3 people, 25.00%
Triamcinolone Acetonide: 1 person, 8.33%

What are other side effects people have besides Uveitis? *

Visual Acuity Reduced (reduced clearness of vision): 6 people, 50.00%
Disease Progression: 3 people, 25.00%
Choroidal Neovascularisation (creation of new blood vessels in vascular layer of eye): 3 people, 25.00%
Vitritis (inflammation of the vitreous humour of the eye): 1 person, 8.33%
Vitreous Floaters (spots before the eyes): 1 person, 8.33%
Toxoplasma Serology Positive: 1 person, 8.33%
Optic Disc Disorder (disease of optic disc of eye): 1 person, 8.33%
Ocular Hyperaemia (an abnormally large amount of blood in eye): 1 person, 8.33%
Macular Hole (small break in the macula, the central area of the retina): 1 person, 8.33%
Lacrimation Increased: 1 person, 8.33%

What are the existing conditions these people have? *

Macular Degeneration (painless eye condition that leads to the gradual loss of central vision): 7 people, 58.33%
Choroidal Neovascularisation (creation of new blood vessels in vascular layer of eye): 3 people, 25.00%
Toxoplasmosis (a parasitic disease caused by the protozoan toxoplasma gondii): 1 person, 8.33%
Nearsightedness (difficulty in seeing the far objects): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Visudyne and have Uveitis?

- Check whether Uveitis is associated with a drug or a condition (FREE)
- Predict drug outcomes for up to one year with AI (FREE)
- Get an AI agent to monitor your drugs continuously (FREE)

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Visudyne:

Visudyne (3,124 reports)

Uveitis treatments and more:

Uveitis (29,545 reports)

Browse all side effects of Visudyne:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Uveitis:

Uveitis (852 drugs)

Browse all the conditions that are associated with Uveitis:

Uveitis (1,501 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on verteporfin (the active ingredients of Visudyne) and Visudyne (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.